Keywords: Anaplastic Thyroid Carcinoma, Dna Damage, Irradiation, Oncolytic Virus, 2 Morpholino 6 (1 Thianthrenyl) 4 Pyranone, Atm Protein, Checkpoint Kinase 1, D 922 947, Gamma Histone H2ax, Mre11 Protein, Nibrin, Oncolytic Adenovirus, Rad50 Protein, Unclassified Drug, Adenovirus Infection, Animal Experiment, Animal Model, Article, Cancer Radiotherapy, Carcinoma Cell, Cell Death, Cell Killing, Controlled Study, Dna Repair, Drug Cytotoxicity, Drug Effect, Drug Efficacy, Histone Phosphorylation, Human, Human Cell, In Vivo Study, Ionizing Radiation, Life Cycle, Mouse, Multimodal Chemotherapy, Nonhuman, Oncolytic Virotherapy, Tumor Xenograft, Virus Entry, Virus Replication,
Affiliations: *** IBB - CNR ***
Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia, Università di Napoli Federico II, via S. Pansini 5, 80131 Napoli, Italy
Beatson Institute for Cancer Research, Switchback Road, Bearsden, Glasgow G61 1BD, United Kingdom
Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale Delle Ricerche, Napoli, Italy
Dipartimento di Diagnostica per Immagini e Radioterapia, Università Federico II, Napoli, Italy
Barts Cancer Institute, Centre for Molecular Oncology, Queen Mary University of London, London, United Kingdom
Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, United States
References: Abou El Hassan, M.A., Van Der Meulen-Muileman, I., Abbas, S., Kruyt, F.A., Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosislike programmed cell death (2004) Journal of Virology, 78, pp. 12243-12251. , (doi:10.1128/JVI.78.22.12243-12251.2004
Anders, M., Christian, C., McMahon, M., McCormick, F., Korn, W.M., Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells (2003) Cancer Research, 63, pp. 2088-2095
Baird, S.K., Aerts, J.L., Eddaoudi, A., Lockley, M., Lemoine, N.R., McNeish, I.A., Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer (2008) Oncogene, 27, pp. 3081-3090. , (doi:10.1038/sj.onc. 1210977)
Bhattacharyya, M., Francis, J., Eddouadi, A., Lemoine, N.R., Hallden, G., An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine (2011) Cancer Gene Therapy, 18, pp. 734-743. , (doi:10.1038/cgt.2011.45)
Bieler, A., Mantwill, K., Holzmuller, R., Jurchott, K., Kaszubiak, A., Stark, S., Glockzin, G., Gansbacher, B., Impact of radiation therapy on the oncolytic adenovirus dl520: Implications on the treatment of glioblastoma (2008) Radiotherapy and Oncology, 86, pp. 419-427. , (doi:10.1016/j.radonc.2007.10.009)
Botta, G., Perruolo, G., Libertini, S., Cassese, A., Abagnale, A., Beguinot, F., Formisano, P., Portella, G., PED/PEA-15 modulates coxsackievirusadenovirus receptor expression and adenoviral infectivity via ERK-mediated signals in glioma cells (2010) Human Gene Therapy, 21, pp. 1067-1076. , (doi:10.1089/hum.2009.181)
Botta, G., Passaro, C., Libertini, S., Abagnale, A., Barbato, S., Maione, A.S., Hallden, G., Portella, G., Inhibition of autophagy enhances the effects of E1A-defective oncolytic adenovirus dl922-947 against glioma cells in vitro and in vivo (2012) Human Gene Therapy, 23, pp. 623-634. , (doi:10.1089/hum.2011.120)
Cheong, S.C., Wang, Y., Meng, J.H., Hill, R., Sweeney, K., Kirn, D., Lemoine, N.R., Hallden, G., E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models (2008) Cancer Gene Therapy, 15, pp. 40-50. , (doi:10.1038/sj.cgt.7701099)
Connell, C.M., Shibata, A., Tookman, L.A., Archibald, K.M., Flak, M.B., Pirlo, K.J., Lockley, M., McNeish, I.A., Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells (2011) Journal of Clinical Investigation, 121, pp. 1283-1297. , (doi:10.1172/JCI43976)
Davy, C., Doorbar, J., G2/M cell cycle arrest in the life cycle of viruses (2007) Virology, 368, pp. 219-226. , (doi:10.1016/j.virol.2007.05.043)
Eager, R.M., Nemunaitis, J., Clinical development directions in oncolytic viral therapy (2011) Cancer Gene Therapy, 18, pp. 305-317. , (doi:10.1038/ cgt.2011.7)
Geoerger, B., Grill, J., Opolon, P., Morizet, J., Aubert, G., Lecluse, Y., Van Beusechem, V.W., Vassal, G., Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts (2003) British Journal of Cancer, 89, pp. 577-584. , (doi:10.1038/sj.bjc.6601102)
Heise, C., Sampson-Johannes, A., Williams, A., McCormick, F., Von Hoff, D.D., Kirn, D.H., ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents (1997) Nature Medicine, 3, pp. 639-645. , (doi:10.1038/nm0697-639)
Heise, C., Hermiston, T., Johnson, L., Brooks, G., Sampson-Johannes, A., Williams, A., Hawkins, L., Kirn, D., A An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy (2000) Nature Medicine, 6, pp. 1134-1139. , (doi:10.1038/80474)
Heise, C., Lemmon, M., Kirn, D., B Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: Dependence on sequencing but not p53 functional status or route of administration (2000) Clinical Cancer Research, 6, pp. 4908-4914
Hickson, I., Zhao, Y., Richardson, C.J., Green, S.J., Martin, N.M., Orr, A.I., Reaper, P.M., Smith, G.C., Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM (2004) Cancer Research, 64, pp. 9152-9159. , (doi:10.1158/ 0008-5472.CAN-04-2727)
Immonen, A., Vapalahti, M., Tyynela, K., Hurskainen, H., Sandmair, A., Vanninen, R., Langford, G., Yla-Herttuala, S., AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: A randomised, controlled study (2004) Molecular Therapy, 10, pp. 967-972. , (doi:10.1016/j.ymthe.2004.08.002)
Jiang, H., Gomez-Manzano, C., Lang, F.F., Alemany, R., Fueyo, J., Oncolytic adenovirus: Preclinical and clinical studies in patients with human malignant gliomas (2009) Current Gene Therapy, 9, pp. 422-427. , (doi:10.2174/ 156652309789753356)
Kuroda, S., Fujiwara, T., Shirakawa, Y., Yamasaki, Y., Yano, S., Uno, F., Tazawa, H., Noma, K., Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery (2010) Cancer Research, 70, pp. 9339-9348. , (doi:10.1158/0008-5472.CAN-10-2333)
Lamfers, M.L., Grill, J., Dirven, C.M., Van Beusechem, V.W., Geoerger, B., Van Den Berg, J., Alemany, R., Vassal, G., Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy (2002) Cancer Research, 62, pp. 5736-5742
Lao-Sirieix, P., Brais, R., Lovat, L., Coleman, N., Fitzgerald, R.C., Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis (2004) Neoplasia, 6, pp. 751-760. , (doi:10.1593/neo.04280)
Lavin, M.F., ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks (2007) Oncogene, 26, pp. 7749-7758. , (doi:10.1038/sj.onc.1210880)
Libertini, S., Iacuzzo, I., Ferraro, A., Vitale, M., Bifulco, M., Fusco, A., Portella, G., Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its antineoplastic activity against anaplastic thyroid carcinoma cells (2007) Endocrinology, 148, pp. 5186-5194. , (doi:10.1210/ en.2007-0752)
Lilley, C.E., Schwartz, R.A., Weitzman, M.D., Using or abusing: Viruses and the cellular DNA damage response (2007) Trends in Microbiology, 15, pp. 119-126. , (doi:10.1016/j.tim.2007.01.003)
Lin, S.F., Gao, S.P., Price, D.L., Li, S., Chou, T.C., Singh, P., Huang, Y.Y., Wong, R.J., Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer (2008) Clinical Cancer Research, 14, pp. 1519-1528. , (doi:10.1158/1078-0432.CCR-07-4628)
Lin, S.F., Price, D.L., Chen, C.H., Brader, P., Li, S., Gonzalez, L., Zhang, Q., Szalay, A.A., Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo (2008) Journal of Clinical Endocrinology and Metabolism, 93, pp. 4403-4407. , (doi:10.1210/jc.2008-0316)
Lisby, M., Barlow, J.H., Burgess, R.C., Rothstein, R., Choreography of the DNA damage response: Spatiotemporal relationships among checkpoint and repair proteins (2004) Cell, 118, pp. 699-713. , (doi:10.1016/j.cell.2004. 08.015)
Liu, C., Sarkaria, J.N., Petell, C.A., Paraskevakou, G., Zollman, P.J., Schroeder, M., Carlson, B., James, C.D., Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme (2007) Clinical Cancer Research, 13, pp. 7155-7165. , (doi:10.1158/1078-0432.CCR-07-1306)
Lockley, M., Fernandez, M., Wang, Y., Li, N.F., Conroy, S., Lemoine, N., McNeish, I., Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: Comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin (2006) Cancer Research, 66, pp. 989-998. , (doi:10.1158/0008-5472.CAN-05-2691)
Nichols, G.J., Schaack, J., Ornelles, D.A., Widespread phosphorylation of histone H2AX by species C adenovirus infection requires viral DNA replication (2009) Journal of Virology, 83, pp. 5987-5998. , (doi:10.1128/ JVI.00091-09)
Oberg, D., Yanover, E., Adam, V., Sweeney, K., Costas, C., Lemoine, N.R., Hallden, G., Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers (2010) Clinical Cancer Research, 16, pp. 541-553. , (doi:10.1158/ 1078-0432.CCR-09-1960)
O'shea, C.C., Johnson, L., Bagus, B., Choi, S., Nicholas, C., Shen, A., Boyle, L., Kunich, J., Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity (2004) Cancer Cell, 6, pp. 611-623. , (doi:10.1016/j.ccr.2004.11.012)
Portella, G., Scala, S., Vitagliano, D., Vecchio, G., Fusco, A., ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines (2002) Journal of Clinical Endocrinology and Metabolism, 87, pp. 2525-2531. , (doi:10.1210/jc.87.6.2525)
Portella, G., Pacelli, R., Libertini, S., Cella, L., Vecchio, G., Salvatore, M., Fusco, A., ONYX-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells (2003) Journal of Clinical Endocrinology and Metabolism, 88, pp. 5027-5032. , (doi:10.1210/jc.2003-030385)
Qian, J., Yang, J., Dragovic, A.F., Abu-Isa, E., Lawrence, T.S., Zhang, M., Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2 (2005) Cancer Research, 65, pp. 5493-5497. , (doi:10.1158/0008-5472. CAN-04-4526)
Radhakrishnan, S., Miranda, E., Ekblad, M., Holford, A., Pizarro, M.T., Lemoine, N.R., Hallden, G., Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts (2010) Human Gene Therapy, 21, pp. 1311-1325. , (doi:10.1089/hum.2010.019)
Schweppe, R.E., Klopper, J.P., Korch, C., Pugazhenthi, U., Benezra, M., Knauf, J.A., Fagin, J.A., Smallridge, R.C., Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification (2008) Journal of Clinical Endocrinology and Metabolism, 93, pp. 4331-4341. , (doi:10.1210/jc.2008-1102)
Seidman, M.A., Hogan, S.M., Wendland, R.L., Worgall, S., Crystal, R.G., Leopold, P.L., Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle (2001) Molecular Therapy, 4, pp. 13-21. , (doi:10.1006/mthe.2001. 0414)
Sherr, C.J., McCormick, F., The RB and p53 pathways in cancer (2002) Cancer Cell, 2, pp. 103-112. , (doi:10.1016/S1535-6108(02) 00102-2)
Smith, J., Tho, L.M., Xu, N., Gillespie, D.A., The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer (2010) Advances in Cancer Research, 108, pp. 73-112. , (doi:10.1016/B978-0-12-380888-2.00003-0)
Taccaliti, A., Silvetti, F., Palmonella, G., Boscaro, M., Anaplastic thyroid carcinoma (2012) Frontiers InEndocrinology, 384. , (doi:10 3389/fendo.2012.00084)
Tallarida, R.J., Drug synergism: Its detection and applications (2001) Journal of Pharmacological and Experimental Therapeutics, 298, pp. 865-872
Touchefeu, Y., Vassaux, G., Harrington, K.J., Oncolytic viruses in radiation oncology (2011) Radiotherapy and Oncology, 99, pp. 262-270. , (doi:10.1016/j.radonc.2011.05.078)
Vichai, V., Kirtikara, K., Sulforhodamine B colorimetric assay for cytotoxicity screening (2006) Nature Protocols, 1, pp. 1112-1116. , (doi:10.1038/ nprot.2006.179)
Ward, I.M., Chen, J., Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress (2001) Journal of Biological Chemistry, 276, pp. 47759-47762. , (doi:10.1074/jbc. M009785200)
Yong, R.L., Shinojima, N., Fueyo, J., Gumin, J., Vecil, G.G., Marini, F.C., Bogler, O., Lang, F.F., Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas (2009) Cancer Research, 69, pp. 8932-8940. , (doi:10.1158/0008-5472.CAN-08-3873)
Zhang, M., Li, S., Li, J., Ensminger, W.D., Lawrence, T.S., Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts (2003) Molecular Therapy, 8, pp. 21-28. , (doi:10.1016/S1525-0016(03) 00143-6)
Abou El Hassan, M. A., Van Der Meulen-Muileman, I., Abbas, S., Kruyt, F. A., Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosislike programmed cell death (2004) Journal of Virology, 78, pp. 12243-12251. , (doi: 10. 1128/JVI. 78. 22. 12243-12251. 2004
Baird, S. K., Aerts, J. L., Eddaoudi, A., Lockley, M., Lemoine, N. R., McNeish, I. A., Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer (2008) Oncogene, 27, pp. 3081-3090. , (doi: 10. 1038/sj. onc. 1210977)
Cheong, S. C., Wang, Y., Meng, J. H., Hill, R., Sweeney, K., Kirn, D., Lemoine, N. R., Hallden, G., E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models (2008) Cancer Gene Therapy, 15, pp. 40-50. , (doi: 10. 1038/sj. cgt. 7701099)
Connell, C. M., Shibata, A., Tookman, L. A., Archibald, K. M., Flak, M. B., Pirlo, K. J., Lockley, M., McNeish, I. A., Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells (2011) Journal of Clinical Investigation, 121, pp. 1283-1297. , (doi: 10. 1172/JCI43976)
Eager, R. M., Nemunaitis, J., Clinical development directions in oncolytic viral therapy (2011) Cancer Gene Therapy, 18, pp. 305-317. , (doi: 10. 1038/ cgt. 2011. 7)
Lamfers, M. L., Grill, J., Dirven, C. M., Van Beusechem, V. W., Geoerger, B., Van Den Berg, J., Alemany, R., Vassal, G., Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy (2002) Cancer Research, 62, pp. 5736-5742
Lavin, M. F., ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks (2007) Oncogene, 26, pp. 7749-7758. , (doi: 10. 1038/sj. onc. 1210880)
Lilley, C. E., Schwartz, R. A., Weitzman, M. D., Using or abusing: Viruses and the cellular DNA damage response (2007) Trends in Microbiology, 15, pp. 119-126. , (doi: 10. 1016/j. tim. 2007. 01. 003)
Lin, S. F., Gao, S. P., Price, D. L., Li, S., Chou, T. C., Singh, P., Huang, Y. Y., Wong, R. J., Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer (2008) Clinical Cancer Research, 14, pp. 1519-1528. , (doi: 10. 1158/1078-0432. CCR-07-4628)
Lin, S. F., Price, D. L., Chen, C. H., Brader, P., Li, S., Gonzalez, L., Zhang, Q., Szalay, A. A., Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo (2008) Journal of Clinical Endocrinology and Metabolism, 93, pp. 4403-4407. , (doi: 10. 1210/jc. 2008-0316)
Nichols, G. J., Schaack, J., Ornelles, D. A., Widespread phosphorylation of histone H2AX by species C adenovirus infection requires viral DNA replication (2009) Journal of Virology, 83, pp. 5987-5998. , (doi: 10. 1128/ JVI. 00091-09)
O'shea, C. C., Johnson, L., Bagus, B., Choi, S., Nicholas, C., Shen, A., Boyle, L., Kunich, J., Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity (2004) Cancer Cell, 6, pp. 611-623. , (doi: 10. 1016/j. ccr. 2004. 11. 012)
Schweppe, R. E., Klopper, J. P., Korch, C., Pugazhenthi, U., Benezra, M., Knauf, J. A., Fagin, J. A., Smallridge, R. C., Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification (2008) Journal of Clinical Endocrinology and Metabolism, 93, pp. 4331-4341. , (doi: 10. 1210/jc. 2008-1102)
Seidman, M. A., Hogan, S. M., Wendland, R. L., Worgall, S., Crystal, R. G., Leopold, P. L., Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle (2001) Molecular Therapy, 4, pp. 13-21. , (doi: 10. 1006/mthe. 2001. 0414)
Sherr, C. J., McCormick, F., The RB and p53 pathways in cancer (2002) Cancer Cell, 2, pp. 103-112. , (doi: 10. 1016/S1535-6108 (02) 00102-2)
Smallridge, R. C., Marlow, L. A., Copland, J. A., Anaplastic thyroid cancer: Molecular pathogenesis and emerging therapies (2009) Endocrine-Related Cancer, 16, pp. 17-44. , (doi: 10. 1677/ERC-08-0154)
Smith, J., Tho, L. M., Xu, N., Gillespie, D. A., The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer (2010) Advances in Cancer Research, 108, pp. 73-112. , (doi: 10. 1016/B978-0-12-380888-2. 00003-0)
Tallarida, R. J., Drug synergism: Its detection and applications (2001) Journal of Pharmacological and Experimental Therapeutics, 298, pp. 865-872
Ward, I. M., Chen, J., Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress (2001) Journal of Biological Chemistry, 276, pp. 47759-47762. , (doi: 10. 1074/jbc. M009785200)
Yong, R. L., Shinojima, N., Fueyo, J., Gumin, J., Vecil, G. G., Marini, F. C., Bogler, O., Lang, F. F., Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas (2009) Cancer Research, 69, pp. 8932-8940. , (doi: 10. 1158/0008-5472. CAN-08-3873)
Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells